ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,948Medicare Part D Prescriptions Filled, Including Refills

Rank: 341 out of 3001

$669K Total Retail Price of All Prescriptions

Rank: 319 out of 3001

527 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 527 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 527 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,142 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 392 346 1 3
POTASSIUM CHLORIDE 355 326 2 15
METFORMIN HCL 353 293 3 9
SIMVASTATIN 347 301 4 1
OMEPRAZOLE 301 209 5 4
FUROSEMIDE 282 258 6 6
METOPROLOL TARTRATE 280 226 7 8
LISINOPRIL 273 215 8 2
WARFARIN SODIUM 246 183 9 12
AMLODIPINE BESYLATE 187 179 10 5
ALENDRONATE SODIUM 183 166 11 26
METOPROLOL SUCCINATE 181 177 12 19
GABAPENTIN 166 141 13 14
PAROXETINE HCL 161 130 14 60
HYDROCODONE-ACETAMINOPHEN 137 63 S3 15 7
EVISTA 136 122 16 148
DONEPEZIL HCL 135 135 17 27
NEXIUM 129 108 18 23
NAMENDA 126 119 19 40
HYDROCHLOROTHIAZIDE 116 96 20 10
TRIAMTERENE-HYDROCHLOROTHIAZID 114 107 21 203
SERTRALINE HCL 108 100 22 20
TRIAMTERENE-HCTZ 108 107 22 48
AMOX TR-POTASSIUM CLAVULANATE 105 92 24 143
TRAMADOL HCL 102 84 25 17
TAMSULOSIN HCL 101 93 26 29
OXYBUTYNIN CHLORIDE ER 99 54 27 79
GLYBURIDE 93 77 R 28 62
BISOPROLOL-HYDROCHLOROTHIAZIDE 87 73 29 111
ZOLPIDEM TARTRATE 82 61 30 24
FLUTICASONE PROPIONATE 79 63 31 42
ATORVASTATIN CALCIUM 75 74 32 11
ACTOS 74 55 33 113
CLOPIDOGREL 73 66 34 28
ALLOPURINOL 72 67 35 35
DIGOXIN 69 66 36 65
DIOVAN 69 57 36 50
LANTUS 66 51 38 47
LOSARTAN POTASSIUM 65 65 39 21
POLYETHYLENE GLYCOL 3350 63 50 40 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 41 40 77
CITALOPRAM HBR 62 46 42 16
VERAPAMIL ER 61 43 43 102
PLAVIX 60 55 44 46
NITROFURANTOIN MONO-MACRO 60 32 44 158
ZETIA 60 37 44 69
CARVEDILOL 60 49 44 25
CIPROFLOXACIN HCL 59 52 48 56
PRAVASTATIN SODIUM 59 54 48 13
NAPROXEN SODIUM 58 38 50 341
ATENOLOL 54 51 51 18
CELEBREX 52 52 52 89
AZITHROMYCIN 50 45 53 36
OLANZAPINE 50 45 53 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.